{"id":62065,"date":"2026-05-18T09:38:31","date_gmt":"2026-05-18T13:38:31","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/scotus-upholds-medicare-price-curbs-as-markets-edge-higher-iran-peace-leaks-surface\/62065\/"},"modified":"2026-05-18T09:38:31","modified_gmt":"2026-05-18T13:38:31","slug":"scotus-upholds-medicare-price-curbs-as-markets-edge-higher-iran-peace-leaks-surface","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/scotus-upholds-medicare-price-curbs-as-markets-edge-higher-iran-peace-leaks-surface\/62065\/","title":{"rendered":"SCOTUS Upholds Medicare Price Curbs as Markets Edge Higher; Iran Peace Leaks Surface"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>The U.S. Supreme Court (SCOTUS) rejected a major pharmaceutical industry challenge<\/strong> to the Biden-era Medicare drug price curbs, a landmark ruling that solidifies the government&#39;s power to negotiate prescription drug costs.<\/li>\n<li><strong>U.S. stock indices opened slightly higher<\/strong>, with the <strong>Nasdaq<\/strong> leading at a <strong>0.12% gain<\/strong> to <strong>26,257.20<\/strong>, while the <strong><a href=\"https:\/\/stockmarketwatch.com\/indices\/sp500\/today\" data-internallinksmanager029f6b8e52c=\"3\" title=\"snp500 today\">S&amp;P 500<\/a><\/strong> and <strong><a href=\"https:\/\/stockmarketwatch.com\/indices\/dowjones\/today\" data-internallinksmanager029f6b8e52c=\"1\" title=\"Dow Jones Today\">Dow Jones<\/a><\/strong> saw marginal increases of <strong>0.06%<\/strong> and <strong>0.04%<\/strong>, respectively.<\/li>\n<li><strong>Leaked details of a &quot;modified paper&quot; from Iran<\/strong> suggest a potential multi-stage truce, including a <strong>long-term nuclear freeze<\/strong> and the gradual reopening of the <strong>Strait of Hormuz<\/strong>, though U.S. oil sanction waivers remain unconfirmed.<\/li>\n<li><strong>JPMorgan Chase &amp; Co. (<a href=\"\/stock\/JPM\">JPM<\/a>) CEO Jamie Dimon<\/strong> issued a bullish outlook on artificial intelligence, stating the technology could eventually <strong>&quot;cure cancer&quot;<\/strong> and fundamentally reshape global productivity.<\/li>\n<li><strong>Bayer (<a href=\"\/stock\/BAYRY\">BAYRY<\/a>) received FDA Priority Review<\/strong> for its drug <strong>Hyrnuo (sevabertinib)<\/strong> as a first-line treatment for HER2-mutated non-small cell lung cancer, marking a significant milestone in precision oncology.<\/li>\n<\/ul>\n<h2>Markets Open in Green as Yields Decline<\/h2>\n<p>U.S. equities began the trading week with modest gains as investors reacted to a cooling in <strong>U.S. Treasury yields<\/strong> and a decline in the <strong>U.S. Dollar<\/strong>. The <strong>S&amp;P 500<\/strong> rose <strong>4.51 points<\/strong> to <strong>7,413.01<\/strong>, while <strong>Nasdaq 100 futures<\/strong> extended their gains to <strong>0.5%<\/strong> shortly after the bell.<\/p>\n<p>The decline in the dollar to session lows coincided with a dip in <strong>oil prices<\/strong>, providing some relief to inflationary concerns. <em>Market sentiment remains cautiously optimistic as traders weigh domestic legal rulings against complex geopolitical developments in the Middle East.<\/em><\/p>\n<h2>Big Pharma Dealt Legal Blow by Supreme Court<\/h2>\n<p>In a pivotal decision for the healthcare sector, the <strong>Supreme Court<\/strong> declined to hear a challenge from the pharmaceutical industry regarding <strong>Medicare drug price negotiations<\/strong>. The ruling effectively upholds the <strong>Inflation Reduction Act\u2019s<\/strong> provisions, which allow the government to curb costs on top-selling medications.<\/p>\n<p>The decision is a significant setback for major drugmakers such as AstraZeneca (<a href=\"\/stock\/AZN\">AZN<\/a>), Bristol Myers Squibb (<a href=\"\/stock\/BMY\">BMY<\/a>), and Johnson &amp; Johnson (<a href=\"\/stock\/JNJ\">JNJ<\/a>), who argued the program was unconstitutional. <em>Analysts suggest this could lead to a long-term shift in pharmaceutical profit margins as more drugs become subject to negotiated pricing in 2026 and beyond.<\/em><\/p>\n<h2>Geopolitical Shifts: Iran Peace Proposal and Russia-China Ties<\/h2>\n<p>Leaked documents indicate that <strong>Iran<\/strong> is seeking a multi-stage political truce that would include a <strong>long-term nuclear freeze<\/strong> instead of full dismantling. Under the proposed terms, Iran would transfer <strong>enriched uranium to Russia<\/strong> and move toward a <strong>gradual opening of the Strait of Hormuz<\/strong> with international guarantees.<\/p>\n<p>Simultaneously, regional tensions persist as <strong>Iraq<\/strong> investigates drones launched from its territory against <strong>Saudi Arabia<\/strong>. Despite these frictions, <strong>Russian President Vladimir Putin<\/strong> is reportedly planning a visit to <strong>China<\/strong> in November for the <strong>APEC summit<\/strong>, where the two nations intend to sign approximately <strong>40 bilateral documents<\/strong> to strengthen strategic cooperation.<\/p>\n<h2>Corporate Highlights: JPMorgan\u2019s AI Vision and Bayer\u2019s FDA Win<\/h2>\n<p>JPMorgan Chase &amp; Co. (<a href=\"\/stock\/JPM\">JPM<\/a>) CEO <strong>Jamie Dimon<\/strong> reiterated his belief that <strong>AI<\/strong> is a &quot;transformational&quot; force on par with electricity. Dimon noted that the technology&#39;s ability to process complex biological data could lead to medical breakthroughs, including <strong>cures for various cancers<\/strong>, while potentially reducing the standard workweek.<\/p>\n<p>In the biotech space, Bayer (<a href=\"\/stock\/BAYRY\">BAYRY<\/a>) announced that the <strong>U.S. FDA<\/strong> has granted <strong>Priority Review<\/strong> to its supplemental New Drug Application for <strong>Hyrnuo (sevabertinib)<\/strong>. The drug is being investigated as a <strong>first-line treatment<\/strong> for patients with <strong>HER2-mutated non-small cell lung cancer<\/strong>, a move that could significantly expand its market reach following its initial accelerated approval in late 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways The U.S. Supreme Court (SCOTUS) rejected a major pharmaceutical industry challenge to the Biden-era Medicare drug price curbs, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[4824,174,215,5997,376,17296,647,3703,3806,3807,3808,4664,4763],"class_list":["post-62065","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-geopolitics","tag-jpm","tag-bmy","tag-pharma","tag-jnj","tag-bayry","tag-azn","tag-ai","tag-spy","tag-qqq","tag-dia","tag-iran","tag-medicare"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/62065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=62065"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/62065\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=62065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=62065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=62065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}